Ideaya Biosciences Inc., of South San Francisco, disclosed plans to raise $70 million in an IPO by offering 5 million shares at a price range of $13 to $15. The company plans to list on Nasdaq under the symbol IDYA. J.P. Morgan, Citi and Jefferies are the joint bookrunners on the deal, expected to price next week.